| scholarly article | Q13442814 |
| P2093 | author name string | Denburg JA | |
| Long AA | |||
| Singal DP | |||
| Carbotte RM | |||
| Denburg SD | |||
| P2860 | cites work | The neurological manifestations of systemic lupus erythematosus | Q70861096 |
| Intrathecal IgG synthesis and blood-brain barrier impairment in patients with systemic lupus erythematosus and central nervous system dysfunction | Q71699465 | ||
| Lymphocytotoxic antibodies | Q72137899 | ||
| Cerebral infarction in systemic lupus: association with anticardiolipin antibodies | Q93855660 | ||
| Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g | Q26778365 | ||
| The 1982 revised criteria for the classification of systemic lupus erythematosus | Q29547225 | ||
| Neuropsychiatric manifestations of systemic lupus erythematosus: diagnosis, clinical spectrum, and relationship to other features of the disease | Q33490122 | ||
| Brain-reactive lymphocytotoxic antibodies in the serum of patients with systemic lupus erythematosus | Q35197902 | ||
| The neuropsychiatric manifestations of systemic lupus erythematosus: an overview | Q36462124 | ||
| Autoantibodies to intracellular proteins. Clinical and biologic significance | Q38156751 | ||
| Cerebral disease in systemic lupus erythematosus | Q39831064 | ||
| The natural history of systemic lupus erythematosus by prospective analysis | Q39866953 | ||
| Central nervous system involvement in systemic lupus erythematosus: A review of neuropathologic findings in 57 cases, 1955–1977 | Q39884813 | ||
| CNS lupus. | Q40242784 | ||
| An antineuronal antibody cross-reacting with erythrocytes and lymphocytes in systemic lupus erythematosus | Q41016280 | ||
| Neuropsychological correlates of serum lymphocytotoxic antibodies in systemic lupus erythematosus | Q41418650 | ||
| Cytotoxins in disease. Autocytotoxins in lupus | Q43797024 | ||
| Antibodies Reactive with Neurons in SLE Patients with Neuropsychiatric Manifestations | Q44280850 | ||
| Cerebrospinal fluid immunoglobulins and neuronal antibodies in neuropsychiatric systemic lupus erythematosus and related conditions | Q48222363 | ||
| Brain reactivity of lymphocytotoxic antibodies in systemic lupus erythematosus with and without cerebral involvement | Q48246705 | ||
| Autoantibodies in the cerebrospinal fluid of patients with systemic lupus erythematosus | Q48303518 | ||
| The diversity of neurologic events in systemic lupus erythematosus. Prospective clinical and computed tomographic classification of 82 events in 71 patients | Q48369404 | ||
| Antineuronal antibodies in neuropsychiatric systemic lupus erythematosus | Q48473651 | ||
| Serum lymphocytotoxic antibodies in neuropsychiatric lupus: a serial study | Q48764029 | ||
| Interpretation of cerebrospinal fluid protein assays in various neurologic diseases | Q48800146 | ||
| Failure to detect brain reactivity of lymphocytotoxins in cerebral lupus. | Q49050887 | ||
| Central nervous system involvement in childhood systemic lupus erythematosus | Q49161757 | ||
| The lupus activity criteria count (LACC). | Q52684688 | ||
| Microdroplet Assay of Human Serum Cytotoxins | Q59059757 | ||
| Lymphocyte Cytotoxic Antibodies in Systemic Lupus Erythematosus | Q59078982 | ||
| Association between Lupus Psychosis and Antiribosomal P Protein Antibodies | Q61974605 | ||
| Central nervous system lupus erythematosus. The need for classification | Q66979100 | ||
| Cognitive impairment in systemic lupus erythematosus: a neuropsychological study of individual and group deficits | Q69061693 | ||
| Neuropsychiatric manifestations of systemic lupus erythematosus | Q69078451 | ||
| Increased intrathecal immunoglobulin synthesis of both kappa and lambda types in patients with systemic lupus erythematosus and central nervous system involvement | Q70309832 | ||
| P433 | issue | 4 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | systemic lupus erythematosus | Q1485 |
| antibody | Q79460 | ||
| P304 | page(s) | 249-253 | |
| P577 | publication date | 1990-04-01 | |
| P1433 | published in | Annals of the Rheumatic Diseases | Q4767876 |
| P1476 | title | Serum lymphocytotoxic antibodies and neurocognitive function in systemic lupus erythematosus | |
| P478 | volume | 49 |
| Q41647250 | A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus |
| Q33566318 | A prospective study of psychiatric disorder and cognitive function in systemic lupus erythematosus |
| Q36392326 | Association of cerebrospinal fluid anti-ribosomal p protein antibodies with diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus |
| Q28082493 | Biomarkers for CNS involvement in pediatric lupus |
| Q48115169 | Brain reactive autoantibodies and cognitive impairment in systemic lupus erythematosus |
| Q38034111 | Cognitive and emotional abnormalities in systemic lupus erythematosus: evidence for amygdala dysfunction |
| Q40827014 | Cognitive changes in systemic lupus erythematosus |
| Q35625220 | Cognitive dysfunction and antiphospholipid antibodies in systemic lupus erythematosus |
| Q33567067 | Controversies in lupus: nervous system involvement |
| Q38660157 | Current concepts of neuropsychiatric systemic lupus erythematosus (NP-SLE) |
| Q35549279 | Diagnosis and monitoring of central nervous system involvement in systemic lupus erythematosus: value of F-18 fluorodeoxyglucose PET |
| Q40033911 | Flow cytometric assessment of anti-neuronal antibodies in central nervous system involvement of systemic lupus erythematosus and other autoimmune diseases |
| Q48423132 | Gadolinium-enhanced magnetic resonance imaging of the central nervous system in systemic lupus erythematosus |
| Q74456594 | Hughes (antiphospholipid) syndrome. Clinical features |
| Q39760458 | Identification of autoantigens specific for systemic lupus erythematosus with central nervous system involvement |
| Q39824623 | Increased Risk of Dementia in Patients With Systemic Lupus Erythematosus: A Nationwide Population-Based Cohort Study. |
| Q27477927 | Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: three case reports and a review of the literature |
| Q41274152 | Lymphocyte and neuronal antigens in neuropsychiatric lupus: presence of an elutable, immunoprecipitable lymphocyte/neuronal 52 kd reactivity |
| Q36750522 | Lymphocytotoxic antibodies in SLE: a review of the literature |
| Q53509972 | Lymphocytotoxic antibodies in systemic lupus erythematosus are associated with disease activity irrespective of the presence of neuropsychiatric manifestations. |
| Q40929944 | Nervous system lupus: pathogenesis and rationale for therapy |
| Q36707992 | Neuroimmunopathology in a murine model of neuropsychiatric lupus |
| Q40469520 | Neuropsychiatric Manifestations of Systemic Lupus Erythematosus |
| Q33592162 | Neuropsychiatric systemic lupus erythematosus in elderly people: a case series |
| Q36896792 | Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials |
| Q41032402 | Psychiatric disorder and cognitive impairment in SLE. |
| Q47305410 | Rheumatic diseases are associated with a higher risk of dementia: A nation-wide, population-based, case-control study |
| Q41605531 | Role of autoantibody tests in the diagnostic evaluation of neuropsychiatric systemic lupus erythematosus. |
| Q36204062 | Systemic Lupus Erythematosus with Central Nervous System Involvement |
| Q40371891 | Systemic lupus erythematosus: immunopathogenesis of neurologic dysfunction |
| Q48220131 | The etiology of psychiatric symptoms in patients with systemic lupus erythematosus. |
| Q34680879 | The neuropathology and pathogenesis of systemic lupus erythematosus |
| Q24682977 | The use of laboratory tests in the diagnosis of SLE |
Search more.